Diazyme DZ168A-CON
Ref DZ168A-CON
Diazyme DZ168A-CON is an in vitro diagnostic device (EU IVDD general IVD) made by Diazyme Laboratories, Inc., registered in EUDAMED on 27 Oct 2026 (Basic UDI-DI B-DZ168A-CONQQ) and listed in FDA GUDID since 3 Nov 2016 (UDI-DI D-DZ168A-CONQQ), active as of 7 Nov 2026.
Active
CE IVDD
Valid until
No date given
FDA recalls
Not checked
Documents
None linked in EUDAMED
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDD EUDAMED | NumberB-DZ168A-CONQQ D-DZ168A-CONQQ | Date27 Oct 2026 | StatusActive |
| United States | GUDID listing GUDID | NumberD-DZ168A-CONQQ | Date3 Nov 2016 | StatusListed |
Official records
- EUDAMED public site B-DZ168A-CONQQ
- AccessGUDID record 00817089020153
From the FDA record
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- EUDAMED Basic UDI-DI B-DZ168A-CONQQ registered 27 Oct 2026 Active
- FDA GUDID UDI-DI D-DZ168A-CONQQ listed 3 Nov 2016 Listed
Timeline
- Listed FDA GUDID D-DZ168A-CONQQ
- Registered EUDAMED B-DZ168A-CONQQ
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- Diazyme Direct Enzymatic HbA1c Control Set EUDAMEDDiazyme GUDID
- Generic name
- Glycated haemoglobin (HbA1c) IVD, control
- Model / reference
- DZ168A-CON
- Primary DI / UDI-DI
- D-DZ168A-CONQQ EUDAMED00817089020153 GUDID
- Basic UDI-DI
- B-DZ168A-CONQQ
- EMDN code
- W0101050205 Diabetes controls
- GMDN term
- Glycated haemoglobin (HbA1c) IVD, control
- Device class
- Class IVD General
- EU registration type
- Legacy device (under a directive)
- EU market of registration
- Germany
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | GUDID |
|---|---|---|
| Primary DI / UDI-DI | D-DZ168A-CONQQ | 00817089020153 |
Similar devices in this category
Other devices filed under DIABETES CONTROLS.
- DIABETES CNTL, Smpl, 1x2x0.5mL 91819 by Cliniqa Corporation
- HbA1c, lyophilised hemolysate Level 4 HBA-02.64_092 by Streekziekenhuis Koningin Beatrix
- HbA1c, lyophilised hemolysate Level 6 HBA-02.66_092 by Streekziekenhuis Koningin Beatrix
- MULTI-SYSTEM Hb A1c CAPILLARY CONTROLS (10X2) 4767 by SEBIA
- ARCHITECT 4P52-11 04P5211 by Abbott
- Multichem A1c HB000M by Techno-Path Manufacturing
- extendSURE™ HbA1c Liquid Controls B12396 by Canterbury Scientific, Ltd.
- Multichem A1c 04V0610 by Techno-Path Manufacturing
- MAS Diabetes Liquid Assayed Diabetes Control DBCL-MP by Microgenics Corporation
- HbA1c Control Material 0320200301 by Shenzhen Lifotronic Technology Co., Ltd.